Oral Lesion Biopsy Procedure Note

Date/Time: [Date and start time; end time if tracked]

Location: [clinic / ASC / OR / bedside]

Operator: [Name, credentials]

Assistant(s): [Name(s) and role(s)] (Only include if assistants were present; omit line if none.)

Procedure: [Oral lesion biopsy—incisional / Oral lesion biopsy—excisional] (If multiple, specify each.)

Site(s): [Anatomic subsite(s) with laterality and specific location]

Pre-Procedure Diagnosis: [Provisional diagnosis or clinical impression]

Post-Procedure Diagnosis: [Same as pre-procedure / Updated diagnosis]

Pre-Procedure Clinical Context

[Lesion history summary] (Brief paragraph including onset/duration, evolution over time, associated symptoms, functional impact, prior treatments or observation and response, any prior biopsy/pathology, and relevant risk factors such as tobacco/vaping, alcohol, betel nut, immunosuppression, prior head/neck cancer or radiation, chronic irritation sources. State if clinical photographs were obtained.)

Focused Oral Examination

(Number each lesion consistently; use the same numbering in Procedure Details and Specimen Handling sections.)

• Lesion 1:
  • [Precise anatomic site with laterality]
  • [Size in two dimensions with units]
  • [Morphology/appearance] (e.g., plaque, papule, nodule, ulcer, leukoplakia, erythroplakia, verrucous, exophytic/endophytic)
  • [Color]
  • [Border characteristics] (well-demarcated vs ill-defined, rolled edges, satellite lesions)
  • [Surface] (smooth, keratotic, ulcerated, friable)
  • [Palpation findings] (induration, fixation, tenderness, bleeding)
  • [Proximity to important structures] (ducts, nerves, vessels, teeth)
• Lesion 2: (Include only if additional lesions present; add numbered lesions as needed.)
  • [Precise anatomic site with laterality]
  • [Size in two dimensions with units]
  • [Morphology/appearance]
  • [Color]
  • [Border characteristics]
  • [Surface]
  • [Palpation findings]
  • [Proximity to important structures]

Regional lymph nodes: [Findings for submental, submandibular, jugular chain, etc.] (Include only if examined; if not examined, state reason.)

Indication & Differential Diagnosis

Indication: [Clinical reason for biopsy] (Link specific exam findings to clinical concern; e.g., persistence beyond observation window, suspicious features, failure of conservative management, rule out dysplasia/malignancy.)

Differential diagnosis: [3–6 plausible entities] (Include malignancy explicitly if suspected.)

Biopsy approach: [incisional / excisional] — [Rationale] (e.g., lesion size, location, suspicion level, diagnostic vs therapeutic intent.)

Informed Consent

[Consent obtained from patient / authorized representative]. Discussed procedure, expected benefits, material risks (bleeding, infection, pain, swelling, nerve/duct/tooth injury, scarring, poor healing, inadequate specimen, need for additional procedure), and alternatives (observation, referral, different approach, no treatment). Questions answered; patient agreed to proceed. (If interpreter used, include language and interpreter ID. If patient declined, document informed refusal with reasons and safety-net plan.)

Pre-Procedure Verification

• Time-out completed: [yes / no] (Patient identity verified with two identifiers; correct procedure, site, and laterality confirmed.)
• Allergies reviewed: [yes / no] (List relevant allergies if present.)
• Anticoagulant/antiplatelet status: [reviewed / not applicable]; [Peri-procedural plan if applicable]
• Required equipment available: [yes / no]
• Site marking: [performed / not performed] (If not performed, state reason—e.g., intraoral marking infeasible, continuous attendance exception.)

Procedure Details

Summary: [Incisional / Excisional] biopsy of [number] lesion(s) at [anatomic site(s) with laterality] under [local anesthesia / local anesthesia with topical].

Anesthesia: [Topical agent if used]; [Local anesthetic agent and concentration] [with / without] epinephrine; [Total volume]; Technique: [infiltration / field block / nerve block] (Specify target nerve if nerve block used.)

Preparation: [Patient position]; [Oral preparation if used]; [Retraction method]; [Special precautions if applicable].

Biopsy technique: (Describe in narrative form, selecting relevant details.)

• [Target area selection] (For incisional: include sampling of advancing edge and adjacent normal mucosa when appropriate.)
• [Incision shape and depth]
• [Instrumentation] (blade size, punch size, other instruments)
• [Tissue handling technique to minimize crush artifact]
• [Hemostasis during sampling] (direct pressure / electrocautery / chemical cautery / hemostatic agent)
• [For excisional: planned margin width; state if margins not intended to be diagnostic]
• [Specimen removal] (en bloc vs segmental)
• [Orientation method if applicable] (e.g., suture marking convention); [Margins inked: yes / no / by pathology]

Specimen Handling

(Document each container separately. Specimen identifiers must match lesion numbering above.)

Specimen A: Lesion [number], [exact site with laterality]; [incisional / excisional / punch]; [Orientation markers if present]; Fixative: [formalin / Michel's / other]; Destination: [Pathology lab/service]. Labeled at collection per policy.

Specimen B: (Include only if multiple specimens.) Lesion [number], [exact site with laterality]; [biopsy type]; [Orientation markers]; Fixative: [—]; Destination: [—].

Special studies: [Not indicated / Obtained] (If obtained, specify study and transport medium—e.g., DIF in Michel's medium. If considered but not obtained, state reason.)

Hemostasis & Closure

Hemostasis: [Method(s)] (direct pressure / electrocautery / chemical cautery / topical hemostatic agent / suture ligation); [Hemostasis achieved: yes / no]

Closure: [Primary closure / Secondary intention]. (If closed: [Suture type and size], [Number of sutures], [resorbable / nonresorbable].)

Estimated Blood Loss & Complications

EBL: [mL or minimal]

Complications: [None / List complications and management]

Post-Procedure Condition

[Patient tolerance]; [Condition at end of procedure] (stable, hemostasis confirmed); [Disposition] (home / observation / other).

Post-Procedure Instructions & Follow-Up

Pathology follow-up: Specimen(s) sent to [Pathology lab/service]; [Expected turnaround if known]. Results via [phone / portal / follow-up visit]. Patient instructed to contact clinic if results not received within [timeframe].

Wound care instructions provided: Bleeding control with direct pressure; oral hygiene guidance; diet modifications (soft diet, avoid hot/sharp/spicy foods); activity restrictions; [suture care and removal timeframe if applicable].

Medications: [Analgesic plan]; [Antibiotics if indicated—document indication]; [Other or none].

Return precautions: Seek care urgently for uncontrolled bleeding, rapidly increasing swelling, fever/chills, purulence, worsening pain, difficulty swallowing or breathing, or signs of allergic reaction.

Follow-up plan: [Timeframe for wound check and/or suture removal]; [Alternative plan if unable to attend].

(Meta-instructions: For required elements—consent, time-out, procedure technique, specimen handling, and complications—if not documented in the encounter, insert placeholder stating "Not documented" rather than omitting. Omit optional elements not discussed. Maintain consistent lesion numbering across examination, procedure, and specimen sections. Use specific, measurable descriptors where available. Do not infer or fabricate details not explicitly stated.)